Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
Roswell Park Cancer Institute
Roswell Park Cancer Institute
University of Leipzig
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Nationwide Children's Hospital
National Cancer Institute (NCI)
Massachusetts General Hospital
Pfizer
M.D. Anderson Cancer Center
Dartmouth-Hitchcock Medical Center
George Washington University
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Beth Israel Deaconess Medical Center
Anthos Therapeutics, Inc.
Swedish Orphan Biovitrum
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Kexing Biopharm Co., Ltd.
Children's Hospital of Philadelphia
Baylor College of Medicine
Fred Hutchinson Cancer Center
Fudan University
Celgene
City of Hope Medical Center
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
City of Hope Medical Center
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Children's Hospital Medical Center, Cincinnati
City of Hope Medical Center
Jiangsu HengRui Medicine Co., Ltd.
Hospital Universitari de Bellvitge
Mount Sinai Hospital, Canada
Columbia University
University of Birmingham
University of Southern Denmark
Tampere University Hospital
Rigshospitalet, Denmark
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals